This grant offered by NIH through FDA CTP supports R21 applications analyzing existing U.S. nationally representative datasets related to tobacco use. The focus is on generating innovative scientific ideas, models, or technologies that can significantly impact biomedical or biobehavioral research, aligning with FDA CTP’s regulatory priorities. Emphasis is placed on datasets informing tobacco regulatory actions, with potential to influence FDA’s regulation of tobacco products for public health protection. Applications must justify the uniqueness of datasets if not nationally representative. Closing date for submissions is March 8, 2021, aiming to advance research crucial for FDA’s oversight of tobacco product manufacturing, distribution, and marketing.
Opportunity ID: 318127
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-OD-19-022 |
| Funding Opportunity Title: | Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.077 — Family Smoking Prevention and Tobacco Control Act Regulatory Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 08, 2019 |
| Last Updated Date: | Jul 08, 2019 |
| Original Closing Date for Applications: | Mar 08, 2021 |
| Current Closing Date for Applications: | Mar 08, 2021 |
| Archive Date: | Apr 13, 2021 |
| Estimated Total Program Funding: | $1,000,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Small businesses Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) City or township governments Public housing authorities/Indian housing authorities County governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite R21 applications proposing the innovative analysis of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the FDA CTP. Other publicly available data sets would be considered depending on the analyses to be conducted; however, nationally representative analyses will receive priority. Applications not using nationally representative data sets will need to provide justification why the data set is unique, and the research questions cant be answered from a (publicly available) national representative data set. This FOA encourages the analyses of public use datasets that may inform tobacco regulatory actions in the U.S. The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA’s regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-022.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00252726 | Sep 09, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259774 | Sep 09, 2019 | Mar 08, 2021 | View |
Package 1
Mandatory forms
318127 RR_SF424_2_0-2.0.pdf
318127 PHS398_CoverPageSupplement_4_0-4.0.pdf
318127 RR_OtherProjectInfo_1_4-1.4.pdf
318127 PerformanceSite_2_0-2.0.pdf
318127 RR_KeyPersonExpanded_2_0-2.0.pdf
318127 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
318127 RR_Budget_1_4-1.4.pdf
318127 RR_SubawardBudget30_1_4-1.4.pdf
318127 PHS398_ModularBudget_1_2-1.2.pdf
318127 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
318127 RR_SF424_2_0-2.0.pdf
318127 PHS398_CoverPageSupplement_5_0-5.0.pdf
318127 RR_OtherProjectInfo_1_4-1.4.pdf
318127 PerformanceSite_2_0-2.0.pdf
318127 RR_KeyPersonExpanded_2_0-2.0.pdf
318127 PHS398_ResearchPlan_4_0-4.0.pdf
318127 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
318127 RR_Budget_1_4-1.4.pdf
318127 RR_SubawardBudget30_1_4-1.4.pdf
318127 PHS398_ModularBudget_1_2-1.2.pdf
318127 PHS_AssignmentRequestForm_3_0-3.0.pdf